A detailed history of Almitas Capital LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 21,478 shares of FLGT stock, worth $625,009. This represents 0.23% of its overall portfolio holdings.

Number of Shares
21,478
Previous 21,478 -0.0%
Holding current value
$625,009
Previous $485,000 -0.0%
% of portfolio
0.23%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$17.18 - $22.6 $164,618 - $216,553
-9,582 Reduced 30.85%
21,478 $485,000
Q2 2025

Aug 14, 2025

BUY
$16.86 - $21.81 $39,486 - $51,079
2,342 Added 8.16%
31,060 $617,000
Q1 2025

May 15, 2025

BUY
$15.28 - $18.95 $194,331 - $241,006
12,718 Added 79.49%
28,718 $485,000
Q4 2024

Feb 14, 2025

BUY
$16.71 - $22.68 $267,360 - $362,880
16,000 New
16,000 $295,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $881M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Almitas Capital LLC Portfolio

Follow Almitas Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almitas Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Almitas Capital LLC with notifications on news.